The introduction of caAkt1 effectively restored Akt-S6K phosphorylation in YME1L-silenced NPC cells and counteracted the inhibitory effects of YME1L shRNA on cell proliferation, migration, and apoptosis. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.